NasdaqGS - Nasdaq Real Time Price USD
Vor Biopharma Inc. (VOR)
0.2343
+0.0344
+(17.21%)
At close: June 2 at 4:00:00 PM EDT
0.2348
+0.00
+(0.21%)
Pre-Market: 4:22:18 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.22 | -0.11 | -0.64 | -0.34 |
| Low Estimate | -0.32 | -0.17 | -0.7 | -0.6 |
| High Estimate | -0.17 | -0.02 | -0.58 | -0.07 |
| Year Ago EPS | -0.41 | -0.4 | -1.7 | -0.64 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.41 | -0.4 | -0.31 | -0.21 |
| EPS Actual | -0.41 | -0.4 | -0.44 | -0.26 |
| Difference | 0 | 0 | -0.13 | -0.05 |
| Surprise % | 1.04% | 1.06% | -43.48% | -25.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.22 | -0.11 | -0.64 | -0.34 |
| 7 Days Ago | -0.19 | -0.1 | -0.59 | -0.9 |
| 30 Days Ago | -0.24 | -0.23 | -0.9 | -0.9 |
| 60 Days Ago | -0.26 | -0.26 | -1.01 | -1.15 |
| 90 Days Ago | -0.31 | -0.32 | -1.15 | -1.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | 1 |
| Up Last 30 Days | 3 | 2 | 4 | 3 |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 1 | 1 | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VOR | 46.95% | 72.50% | 62.21% | 47.08% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Downgrade | JMP Securities: Market Outperform to Market Perform | 5/9/2025 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 5/9/2025 |
| Reiterates | Oppenheimer: Outperform to Outperform | 3/21/2025 |
| Maintains | Stifel: Buy to Buy | 3/21/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/21/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
Related Tickers
DSGN Design Therapeutics, Inc.
4.0200
+7.77%
CGEM Cullinan Therapeutics, Inc.
8.75
+1.21%
ATHA Athira Pharma, Inc.
0.2851
-8.77%
PASG Passage Bio, Inc.
0.4362
-0.02%
TNFA TNF Pharmaceuticals, Inc.
0.1710
+6.61%
GBIO Generation Bio Co.
0.3845
+1.67%
MRSN Mersana Therapeutics, Inc.
0.3739
+8.79%
BCAB BioAtla, Inc.
0.5100
+24.69%
ONCO Onconetix, Inc.
0.0800
+2.56%
ABP Abpro Corporation
0.2199
+2.90%